Cargando…

Macrophage dysfunction in Psoriatic Arthritis

Detalles Bibliográficos
Autores principales:	Wenink, Mark H, Santegoets, Kim CM, van Bon, Lenny, Butcher, John, van den Berg, Wim B, van Riel, Piet LCM, McInnes, Iain B, Radstake, Timothy RDJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242289/ http://dx.doi.org/10.1186/1479-5876-9-S2-P59

Ejemplares similares

Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis
por: Wenink, Mark H, et al.
Publicado: (2011)

Fc Gamma Receptor IIb on GM-CSF Macrophages Controls Immune Complex Mediated Inhibition of Inflammatory Signals
por: Santegoets, Kim C. M., et al.
Publicado: (2014)

Synovial Tissue Response to Treatment in Psoriatic Arthritis
por: Codullo, Veronica, et al.
Publicado: (2011)

Soluble Immune Complexes Shift the TLR-Induced Cytokine Production of Distinct Polarized Human Macrophage Subsets towards IL-10
por: Ambarus, Carmen A., et al.
Publicado: (2012)

Immune complexes shift the TLR-induced cytokine production of distinct polarized human macrophage subsets towards IL-10
por: Ambarus, Carmen, et al.
Publicado: (2011)

Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
por: Mease, Philip, et al.
Publicado: (2016)

Immune responses to stress after stress management training in patients with rheumatoid arthritis
por: de Brouwer, Sabine JM, et al.
Publicado: (2013)

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005)

Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways
por: Johnsson, Hanna, et al.
Publicado: (2023)

Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, Toll-like receptors and rheumatoid synovial fluid
por: van Lieshout, Antoine WT, et al.
Publicado: (2006)

Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression
por: Radstake, Timothy R. D. J., et al.
Publicado: (2009)

MicroRNAs underlie plasmacytoid dentritic cell dysfunction in systemic sclerosis
por: Broen, Jasper C, et al.
Publicado: (2012)

Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses
por: de Brouwer, Sabine JM, et al.
Publicado: (2010)

CD4+CD45RA+ T-cells from early diffuse systemic sclerosis patients produce high levels of interleukin-17
por: van Bon, Lenny, et al.
Publicado: (2011)

Metatarsophalangeal joint pain in psoriatic arthritis: a cross-sectional study
por: Turner, Deborah E., et al.
Publicado: (2014)

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)

Identification of distinct polarized macrophage subsets in inflammatory arthritis
por: Ambarus, C, et al.
Publicado: (2010)

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis
por: Jongbloed, Sarah L, et al.
Publicado: (2006)

Local IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammation
por: Nabbe, Karin CAM, et al.
Publicado: (2005)

Determinants of work and social participation in patients with psoriatic arthritis in the Netherlands: an observational study
por: van Hal, Tamara W., et al.
Publicado: (2022)

Outcome measures in inflammatory rheumatic diseases
por: Fransen, Jaap, et al.
Publicado: (2009)

Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study
por: Flendrie, Marcel, et al.
Publicado: (2005)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
por: Ogdie, Alexis, et al.
Publicado: (2020)

Toll-like receptor 4 polymorphism influences susceptibility to but not severity and outcome of rheumatoid arthritis
por: Radstake, TRDJ, et al.
Publicado: (2004)

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials
por: Mease, Philip J, et al.
Publicado: (2021)

Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis
por: Hendrikx, Jos, et al.
Publicado: (2016)

Exercise participation has increased in patients with Rheumatoid Arthritis: A cross-sectional comparison between two Dutch RA cohorts
por: Weijers, Julia M., et al.
Publicado: (2018)

The characterisation and regulation of type 1 immune responses in psoriatic arthritis
por: Gracie, JA, et al.
Publicado: (2002)

Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank
por: Ferguson, Lyn D, et al.
Publicado: (2019)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis
por: van der Heijde, Désirée, et al.
Publicado: (2016)

Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
por: van den Bemt, Bart JF, et al.
Publicado: (2011)

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
por: Mease, Philip J., et al.
Publicado: (2020)

Ustekinumab Treatment and Improvement of Physical Function and Health‐Related Quality of Life in Patients With Psoriatic Arthritis
por: Rahman, Proton, et al.
Publicado: (2016)

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
por: Charles-Schoeman, Christina, et al.
Publicado: (2023)

Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study
por: Ferguson, Lyn D, et al.
Publicado: (2021)

Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort
por: VAN HAL, Tamara W., et al.
Publicado: (2022)

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes
por: McInnes, Iain B, et al.
Publicado: (2022)

Telomere biology is differently affected within clinical subsets of systemic sclerosis and points towards different downstream defects
por: Broen, Jasper CA, et al.
Publicado: (2012)

Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review
por: Mulder, Michelle L. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ceculueqoa0npcik3ef35gemt